Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts.
Veenhuizen SGA, van Grinsven SEL, Laseur IL, Bakker MF, Monninkhof EM, de Lange SV, Pijnappel RM, Mann RM, Lobbes MBI, Duvivier KM, de Jong MDF, Loo CE, Karssemeijer N, van Diest PJ, Veldhuis WB, van Gils CH; DENSE Trial Study Group. Veenhuizen SGA, et al. Eur Radiol. 2024 Apr 19. doi: 10.1007/s00330-024-10685-9. Online ahead of print. Eur Radiol. 2024. PMID: 38639912
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.
Koekenbier EL, Fohse K, van de Maat JS, Oosterheert JJ, van Nieuwkoop C, Hoogerwerf JJ, Grobusch MP, van den Bosch MAAJ, van de Wijgert JHH, Netea MG, Rosendaal FR, Bonten MJM, Werkhoven CHHV; BCG-PRIME study group. Koekenbier EL, et al. Among authors: van den bosch maaj. Clin Microbiol Infect. 2023 Jun;29(6):781-788. doi: 10.1016/j.cmi.2023.01.019. Epub 2023 Feb 2. Clin Microbiol Infect. 2023. PMID: 36736662 Free PMC article. Clinical Trial.
Clinical characteristics and risk factors of preventable hospital readmissions within 30 days.
Meurs EAIM, Siegert CEH, Uitvlugt E, Morabet NE, Stoffels RJ, Schölvinck DW, Taverne LF, Hulshof PBJE, Ten Horn HJS, Noordman PCW, van Es J, van der Heijde N, van der Ree MH, van den Bosch MAAJ, Karapinar-Çarkit F. Meurs EAIM, et al. Among authors: van den bosch maaj. Sci Rep. 2021 Oct 11;11(1):20172. doi: 10.1038/s41598-021-99250-8. Sci Rep. 2021. PMID: 34635681 Free PMC article. Clinical Trial.
Reducing False-Positive Screening MRI Rate in Women with Extremely Dense Breasts Using Prediction Models Based on Data from the DENSE Trial.
den Dekker BM, Bakker MF, de Lange SV, Veldhuis WB, van Diest PJ, Duvivier KM, Lobbes MBI, Loo CE, Mann RM, Monninkhof EM, Veltman J, Pijnappel RM, van Gils CH; DENSE Trial Study Group. den Dekker BM, et al. Radiology. 2021 Nov;301(2):283-292. doi: 10.1148/radiol.2021210325. Epub 2021 Aug 17. Radiology. 2021. PMID: 34402665 Clinical Trial.
Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial.
Veenhuizen SGA, de Lange SV, Bakker MF, Pijnappel RM, Mann RM, Monninkhof EM, Emaus MJ, de Koekkoek-Doll PK, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, van Gils CH, Veldhuis WB; DENSE Trial Study Group. Veenhuizen SGA, et al. Among authors: van den bosch maaj. Radiology. 2021 May;299(2):278-286. doi: 10.1148/radiol.2021203633. Epub 2021 Mar 16. Radiology. 2021. PMID: 33724062 Clinical Trial.
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, Veldhuis WB, van Gils CH; DENSE Trial Study Group. Bakker MF, et al. Among authors: van den bosch maaj. N Engl J Med. 2019 Nov 28;381(22):2091-2102. doi: 10.1056/NEJMoa1903986. N Engl J Med. 2019. PMID: 31774954 Clinical Trial.
Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
Braat AJAT, Kwekkeboom DJ, Kam BLR, Teunissen JJM, de Herder WW, Dreijerink KMA, van Rooij R, Krijger GC, de Jong HWAM, van den Bosch MAAJ, Lam MGEH. Braat AJAT, et al. Among authors: van den bosch maaj. BMC Gastroenterol. 2018 Jun 15;18(1):84. doi: 10.1186/s12876-018-0817-8. BMC Gastroenterol. 2018. PMID: 29902988 Free PMC article. Clinical Trial.
230 results